OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Genomics
(2)
Organisms
Homo sapiens
(2)
Repository
EGA
(2)
Technology Type
Illumina 1.2M, Affymetrix 6.0, Affymetrix 6.0 - CHIAMO
(1)
Publication Date
Release Date
2021
(7)
2020
(4)
2024
(3)
2025
(2)
2022
(2)
2011
(2)
2019
(1)
2018
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.
Not available
S-EPMC3172912
|
biostudies-literature
Cite
How do palliative care doctors recognise imminently dying patients? A judgement analysis.
Not available
S-EPMC6254495
|
biostudies-literature
Cite
Single-View Echocardiography by Nonexpert Practitioners to Detect Rheumatic Heart Disease: A Prospective Study of Diagnostic Accuracy.
Not available
S-EPMC8373443
|
biostudies-literature
Cite
PR
Pharmacogenomic response to Statins samples (Genotypes/Phenotypes)
EGAD00010000282
|
EGA
Cite
WTCCC2 Pharmacogenomic Response to Statins study
A WTCCC2 project genome-wide study for pharmacogenomic response to statins (PR) in individuals from Scotland.
EGAS00000000121
|
EGA
Cite
Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50-85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study.
Not available
S-EPMC10884388
|
biostudies-literature
Cite
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Not available
S-EPMC6615016
|
biostudies-literature
Cite
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Not available
S-EPMC3549296
|
biostudies-literature
Cite
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.
Not available
S-EPMC11519785
|
biostudies-literature
Cite
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
Not available
S-EPMC3386495
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets